You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma

Showing 4526 - 4550 of 5,258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Colonic Tumors, Breast Tumors Trial in United States (PD-0325901)

Terminated
  • Melanoma
  • +2 more
  • Birmingham, Alabama
  • +16 more
Sep 11, 2013

Malignant Melanoma Stage IV Trial in Dallas (DC Vaccine & Cyclophosphamide, DC Vaccine & Placebo)

Terminated
  • Malignant Melanoma Stage IV
  • DC Vaccine & Cyclophosphamide
  • DC Vaccine & Placebo
  • Dallas, Texas
    Baylor University Medical Center
Jul 5, 2013

Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia Trial in La Jolla (Nonmyeloablative Allogeneic

Unknown status
  • Aplastic Anemia
  • +17 more
  • Nonmyeloablative Allogeneic Transplant
  • La Jolla, California
    Scripps Green Hospital
Dec 5, 2013

Melanoma Trial in Nashville (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Melanoma
  • bevacizumab
  • +6 more
  • Nashville, Tennessee
  • +3 more
Jul 15, 2013

COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Huntsville, Alabama
  • +94 more
Jul 13, 2015

Impaired Glucose Tolerance, Obesity, Diabetes Trial in Durham (Physical Activity Counseling)

Completed
Has Results
  • Impaired Glucose Tolerance
  • +2 more
  • Physical Activity Counseling
  • Durham, North Carolina
    Durham VA Medical Center, Durham, NC
Apr 6, 2015

Genes and Environment in Cancer in East Anglia, Trent, or West

Unknown status
  • Bladder Cancer
  • +8 more
  • DNA analysis
  • +3 more
  • Cambridge, England, United Kingdom
    University of Cambridge Cancer Research UK
Aug 23, 2013

Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial (dendritic cell-gp100-MART-1 antigen vaccine, sargramostim)

Completed
  • Stage IV Melanoma
  • +2 more
  • (no location specified)
Jun 19, 2013

Melanoma (Skin), Weight Changes Trial (educational intervention)

Completed
  • Melanoma (Skin)
  • Weight Changes
  • educational intervention
  • (no location specified)
Jun 19, 2013

Melanoma (Skin) Trial in Boston, Cambridge (boron neutron capture therapy)

Completed
  • Melanoma (Skin)
  • boron neutron capture therapy
  • Boston, Massachusetts
  • +1 more
Jun 25, 2013

Melanoma (Skin) Trial in New York (QS21, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • QS21
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 24, 2013

Stage IV Melanoma, Recurrent Melanoma Trial run by the NCI (gp100 antigen, interleukin-2)

Completed
  • Stage IV Melanoma
  • Recurrent Melanoma
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Advanced Parkinson's Disease Trial in Worldwide (Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump,

Completed
Has Results
  • Advanced Parkinson's Disease
  • Levodopa-carbidopa intestinal gel
  • +3 more
  • Birmingham, Alabama
  • +82 more
Jan 12, 2015

Intraocular Melanoma, Melanoma (Skin) Trial in New York (temozolomide, thalidomide)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Melanoma (Skin) Trial in Dallas (MART-1 antigen, filgrastim, flu matrix peptide p58-66)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +6 more
  • Dallas, Texas
    Baylor University Medical Center
Jun 25, 2013

Stage IV Melanoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial run by the NCI (flt3 ligand, gp100 antigen,

Completed
  • Stage IV Melanoma
  • +3 more
  • flt3 ligand
  • +4 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Melanoma (Skin) Trial in Milwaukee (aldesleukin, lymphokine-activated killer cells, therapeutic tumor infiltrating lymphocytes)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +4 more
  • Milwaukee, Wisconsin
    St. Luke's Medical Center
Jun 25, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • aldesleukin
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial in New York (acetaminophen, acetylcysteine, carmustine)

Completed
  • Melanoma (Skin)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 24, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, gp100 antigen)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Diabetes, Type 2 Trial in Worldwide (Saxagliptin, Placebo, pioglitazone)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Haleyville, Alabama
  • +132 more
Mar 18, 2015

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Bethesda, Maryland
    Surgery Branch
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, vaccinia-tyrosinase vaccine)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013